Loading…
Keiji AI's TrialMind platform provides end-to-end AI agents that support every phase of the clinical trial lifecycle, from discovery and protocol optimization to data monitoring and biostatistical analysis. The platform is built on over 10 years of AI research, validated by 100+ publications, and deployed by leading pharma, biotech, and CROs to accelerate clinical research at scale.
AI named Keiji.ai in November 2025.